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Abstract  
 
Familial risk and environmental stress promote the development of alcohol dependence. We 
investigated whether a positive family history of alcoholism affects the neuroendocrine response to a 
standardized laboratory stress test in healthy subjects without alcohol use disorders. Twenty-four high-
risk subjects with a paternal history of alcoholism (PHA) and 16 family history negative (FHN) 
controls were evaluated. Psychosocial stress was induced by having subjects deliver a 5-min speech 
and mental arithmetics in front of an audience on separate days, after drinking either placebo or 
ethanol (0.6 g/kg) in a randomized sequence. Adrenocorticotropin (ACTH) was measured in 10 
plasma samples covering up to 75 min after the stress test. Plasma arginine vasopressin (AVP) was 
determined before the stressor, at the time of maximum ACTH secretion, and at 75 min after stress 
onset. The stress test induced a phasic increase in ACTH secretion. At the time of maximum ACTH, 
AVP was significantly increased in relation to baseline. Compared to placebo, alcohol administration 
significantly attenuated maximum ACTH concentration in PHA but not FHN subjects, and decreased 
AVP measured in the same samples in PHA but not FHN subjects. We conclude that activation of the 
hypothalamic–pituitary–adrenal system by psychosocial stress is accompanied by an increase in 
peripheral plasma AVP levels. Secretion of both ACTH and AVP suggest that alcohol attenuates the 
stress response selectively in PHA but not FHN subjects. This might imply some short-term positive 
alcohol effect in sons of alcoholics, but also constitute a mechanism by which their risk to develop 
alcohol use disorders is increased.   
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1. Introduction  
 
Alcoholism runs in families (Cotton, 1979), and twin studies suggest that a substantial part of 
the associated risk is conveyed by genetic factors (Prescott and Kendler, 1999). The social 
environment is also long known to contribute to development and maintenance of alcoholism. 
Stress appears to be a particularly relevant mechanism (for review, see Sinha, 2001), possibly 
by interacting with genetic risk factors (Madrid et al., 2001). One possibility to study how the 
genetic risk manifests itself is to investigate offspring of alcohol-dependent parents who 
themselves have not yet developed alcohol use disorders (for review, see Newlin and 
Thomson, 1990). Using this approach, several authors found that offspring of alcoholics had 
increased autonomic reactivity to aversive electrical shocks and public speaking, and that 
alcohol had a stronger stress response- dampening effect compared to family history negative 
controls (Levenson et al., 1987; Finn et al., 1990; Conrod et al., 1998; Sinha et al., 1998).  
 
We were recently able to extend these findings by investigating adrenocorticotropin (ACTH) 
and cortisol secretion in response to psychosocial stress, which was exaggerated in healthy 
males with a paternal history of alcoholism (PHA) compared to control subjects with a 
negative family history (FHN). In this study, alcohol administration significantly attenuated 
the endocrine stress response in PHA but not in FHN subjects, while pre-stress hormone 
levels did not differ between groups (Zimmermann et al., in press). However, while ACTH 
and cortisol are the core parameters defining a stress response, they provide only indirect 
information about central nervous control of the hypothalamic–pituitary– adrenal (HPA) 
system since they are secreted by peripheral endocrine glands. In an effort to complement 
these data by a parameter which is more closely related to the central nervous processes that 
elicit the HPA activation, this paper reports on arginine vasopressin (AVP) secretion in a 
subgroup of the same subjects. Release of ACTH from the anterior pituitary lobe is stimulated 
by corticotropin releasing hormone (CRH) and AVP. In rodents, the pattern of stress-induced 
ACTH secretagogue activity depends on the type of stressor. The HPA activation elicited by 
physical stress is mainly caused by CRH, while other stressors such as novelty, social 
isolation, restraint, or fear are believed to predominantly result in AVP secretion in animals 
(Romero and Sapolsky, 1996).  
 
The nonapeptides AVP and oxytocin (OXT) are synthesized in, transported by, and secreted 
from two distinct classes of neurons. Magnocellular vasopressinergic and oxytocinergic 
neurons of the hypothalamic paraventricular (PVN), supraoptic, and accessory nuclei 
constitute the hypothalamic–neurohypophyseal system (Hatton, 1990), whereas parvocellular 
vasopressinergic neurons are found in the hypothalamus within the suprachiasmatic nucleus 
(SCN) and the parvocellular part of the PVN (De Vries et al., 1985). The neurons of SCN and 
PVN project predominantly to the median eminence (Alonso and Assenmacher, 1981), where 
AVP and CRH are secreted into the portal blood to act synergistically as secretagogues of 
ACTH at the adenohypophysis (Plotsky, 1991). The parvocellular vasopressinergic system 
originating from the PVN appears to be activated in depressive syndromes (for review, see 
Holsboer and Barden, 1996; for animal model see Wigger et al., 2004), which suggests that 
increased secretion of AVP might contribute to the hyperactivity of the HPA system in major 
depression. This notion is supported by one study reporting increased plasma AVP in 
depressive patients compared to healthy controls (van Londen et al., 1997), while other 
studies found no difference in plasma (Brunner et al., 2002) or cerebrospinal fluid AVP 
(Heuser et al., 1998; Brunner et al., 2002).  
 
In recent years, evidence has been accumulated that both AVP and CRH act not only as 
hormones, but also as neuromodulators and neurotransmitters within the central nervous 
system. Following its central release (Landgraf, 1995) and independent of HPA system 
regulation, AVP appears to be critically involved in a variety of brain functions including 
learning, memory, and emotionality (de Wied et al., 1993; Landgraf, 2001; Engelmann et al., 
1996).  
 
AVP measured in peripheral blood predominantly originates from the magnocellular system 
and is secreted in response to osmotic stimuli, its main function being regulation of osmolality 
(for review, see Lightman, 1990; Hussy et al., 2000). On the other hand, psychological stress 
activates the parvocellular system to release ACTH secretagogues into the hypophyseal portal 
vein system (Herman, 1995; for review, see Romero and Sapolsky, 1996). This was 
associated with an increase in peripheral blood AVP in various animal models (Romero and 
Sapolsky, 1996), and in humans preparing for their first parachute jump (Dugue et al., 1993). 
Pain due to injuries was also associated with increased peripheral AVP levels (Kendler et al., 
1978), while milder stressors such as noise combined with mental arithmetics and cold stress 
(Ehrenreich et al., 1997) did not stimulate AVP secretion.  
 
Several studies investigated alcohol effects on peripheral AVP in humans. Oral dosages of 
0.25 (Gianoulakis et al., 1997), 0.5 (Chiodera and Coiro, 1990; Gianoulakis et al., 1997), or 
0.88 g/kg (Inder et al., 1995) did not alter basal AVP levels, while two studies found a 
decrease after 0.8 g/kg (Eisenhofer and Johnson, 1982) or approximately 0.4 g/kg (Leppaluoto 
et al., 1992). Even a low dosage of approximately 0.5 g/kg almost abolished the rise in AVP 
induced by insulin hypoglycemia (Chiodera and Coiro, 1990). On the other hand, if alcohol 
induced nausea, this was associated with a marked increase of peripheral AVP and ACTH 
(Inder et al., 1995).  
 
These observations lead us to investigate plasma AVP levels in response to a standardized 
laboratory psychosocial stress test that was performed twice in males with a PHA and in FHN 
controls, once being sober and once being moderately alcohol-intoxicated. We hypothesized 
that the stress-induced HPA activation might be accompanied by an increase in peripheral 
blood AVP levels, which might be attenuated by prior alcohol administration. According to 
our findings on ACTH secretion, we expected the AVP response to be higher in PHA 
subjects, and the alcohol effect to be more pronounced in PHA than FHN subjects. In an 
exploratory design, we also investigated whether AVP levels are influenced by potentially 
confounding factors such as plasma osmolality, individual psychiatric comorbidity, or 
personality trait variables.  
 
2. Methods  
 
2.1. Subjects  
 
Recruitment of participants based on a prospective longitudinal epidemiological survey 
investigating a representative sample of 3021 adolescents of the Munich area (Lieb et al., 
2000). Before entering the present study, participants of this survey had been screened twice 
for early developmental stages of psychopathology by means of the Munich Composite 
International Diagnostic Interview (M-CIDI, Lieb et al., 2000). 115 of 1533 male participants 
reported that their father, but not their mother had an alcohol problem. For comparison, 62 
males who denied parental alcohol problems were selected from the same sample by matching 
them for age, history of depressive or anxiety disorders, and alcohol use disorders. These 
subjects were offered participation in the present study during the final epidemiologic 
interview. If they agreed, both parents were interviewed using the alcohol use disorders 
section of the M-CIDI. Additional questions were asked concerning whether alcohol had ever 
caused health or social problems in their parents, brothers or sisters (i.e., the four grandparents 
and blood-related uncles and aunts of the study participants).  
 
Based on the parental interviews, the inclusion criteria for high-risk subjects were a DSM-IV 
diagnosis of alcohol dependence in the father and the absence of an alcohol-related disorder in 
the mother in order to exclude an effect of fetal alcohol syndrome (paternal history of 
alcoholism, PHA). Control subjects were included if M-CIDI interviews confirmed the 
absence of a DSM-IV diagnosis of alcohol use disorders in both parents, and both parents 
denied alcohol problems in their first-grade relatives (family history negative, FHN). General 
inclusion criteria applying for participants of both groups were social alcohol drinking at least 
once every month and consenting to abstain from any illegal substance use during the 
experimental period.  
 
In a high percentage of subjects selected from the epidemiologic survey the inclusion criteria 
were not fulfilled (Table 1). To increase the sample size, also friends of study participants 
were considered for investigation. These subjects and their parents underwent the same 
interviewing procedure as described above to scrutinize inclusion, exclusion, and matching 
criteria. All subjects were of Caucasian ethnicity. The recruitment process is summarized in 
Table 1. During the screening visit a medical history was taken, and a physical examination, 
routine laboratory tests, and a psychiatric interview were performed. Current active alcohol or 
substance abuse and dependence were checked by asking the respective CIDI questions. 
Probands also completed the Beck depression inventory and the sensation seeking scale 
according to Zuckerman et al. (1980). After complete description of the study, written 
informed consent was obtained from all subjects.  
 
After the experiments were performed, two subjects were excluded from evaluation due to a 
positive cannabinoid screen. Data of three others were excluded because, based on post hoc 
criteria, their ACTH responses were thought abnormal: Two FHN subject had abnormally 
high maximum ACTH levels (subject 1: 353 and 256 pg/ml during placebo and alcohol 
experiments, with AVP levels of 2.42 and 1.48 pg/ml, respectively; subject 2: ACTH 87 and 
100 pg/ml, AVP 2.1 and 1.8 pg/ml, respectively). One PHA subject showed chaotic 
decrements and increments of ACTH secretion after the stressor which, contrary to all other 
subjects, did not define an unambiguous local maximum and questioned the occurrence of a 
time-organized stress response. Baseline and maximum AVP in this subject were 0.77 and 
1.05 pg/ml during placebo, and 0.66 and 0.77 during alcohol. Due to technical problems, AVP 
could not be measured in the last 12 subjects, altogether leaving 24 PHA and 16 FHN subjects 
for analysis.  
 
3. Experimental procedures  
 
To investigate reactivity to a psychosocial stressor and its modulation by alcohol, subjects 
were tested twice using the Trier Social Stress Test (Kirschbaum et al., 1993), which requires 
probands to deliver a five minutes-speech and five minutes of mental arithmetics in front of 
three observers unknown to them while being video- and audiotaped. Before the stress tests, 
placebo or alcohol was administered in a double-blind, placebo-controlled crossover-design 
with a minimum of 1 week between study days. The experimenter was blind against the risk 
status of the subjects.  
 
Subjects reported at the laboratory at 1300 h and were asked for recent alcohol use and 
number of cigarettes smoked today. Recent substance use was checked by urine screening. At 
1315 h, an IV line was established and 40 ml/h of 0.9% saline was infused to keep the line 
open for blood drawing. At 1400 and 1420 h, the beverage was administered divided in two 
portions and consumed over 5 min, respectively. The total amount of alcohol was 0.6 g/kg of 
laboratory grade ethanol diluted in ice-cold grapefruit juice to give a concentration of 15% 
(v/v). During drinking, subjects wore a nose-peg to disguise the smell of alcohol. The same 
volume of plain grapefruit juice was given on placebo days. At 1420 and 1430 h, basal blood 
samples were drawn. At 1435 h the subjects were instructed about the test procedures and 
were given 10 min to prepare for their speech. At 1450 h, three health care professionals 
walked into the room to act as an audience and the stress test was performed as described by 
Kirschbaum et al. (1993). Blood samples were taken at the beginning of the preparation time, 
immediately before, and 10, 20, 30, 45, and 60 min after beginning of the stressor. After the 
experiment, subjects rated feelings of nausea using a 100 mm visual analog scale. Breath 
alcohol concentration (BrAC) was measured immediately before and 10, 30, 40, 60, and 80 
min after beginning of the stress test using an Alcotest 7410 breath analyzer (Draeger 
Sicherheitstechnik, Lübeck, Germany). The study protocol was approved by the local ethical 
committee and the experiments were performed in accordance with the declaration of 
Helsinki. Subjects were paid for participation.  
 
 
4. Sample treatment and hormone measurements  
 
Blood samples were drawn in devices pretreated with 8 mg EDTA and aprotinin (2,000 
kallikrein-inhibiting units per 7 ml blood, Bayer, Leverkusen, Germany). The blood was kept 
on ice, spun at 1500g within 60 min, and the plasma frozen at -80 °C. ACTH was measured 
without extraction by a 125I-immunoradiometric assay (Nichols Institute, San Juan Capistrano, 
CA) with a detection limit of 4 pg/ml. The monoclonal antibody did not cross-react with α-
MSH, β-MSH, β-LPH, or β -endorphin. Inter- and intra-assay coefficients of variation at 20 
pg/ml were below 8%.  
 
Due to the high technical expenditure, AVP was not analyzed from all samples. To increase 
the probability of detecting an AVP response to the stressor, we selected in each individual 
the sample yielding maximum post-stress ACTH level for measurement of AVP. For 
comparison, AVP was measured from the samples taken immediately before and 75 min after 
beginning of the stress test. AVP was analyzed after extraction (LiChroprep Si 60; Merck, 
Germany) by a highly sensitive and selective radioimmunoassay (detection limit 0.1 pg/ 
sample; cross-reactivity of the antiserum with other related peptides, including oxytocin 
<0.7%). Intra- and inter-assay coefficients of variation were <8% and <13%, respectively. 
Synthetic AVP (Ferring Pharmaceuticals Ltd., Malmo, Sweden) was used as standard, and 
iodinated nonapeptide (specific activity 2200 Ci/mmol; NEN Life Science Products, Boston, 
MA) was used as a tracer. Polyclonal rabbit antibodies raised in our laboratory were used at a 
dilution of about 1:350,000. The data were not corrected for recovery (80– 85% range).  
 
5. Statistical methods  
 
The effects of the within-subjects factor ‘‘treatment’’ (alcohol vs. placebo) and of the 
between-subjects factors ‘‘risk group’’ (PHA vs. FHN subjects) and ‘‘administration 
sequence’’ (first test placebo/second alcohol vs. first alcohol/second placebo) on baseline 
AVP and ACTH levels measured after drinking, but before the stressor were tested by three-
factorial multivariate analyses of variance (MANOVA) with repeated measures design. Stress 
effects on AVP and ACTH secretion were also tested by repeated-measures MANOVAs. 
Thereby, ‘‘stress’’ (before vs. after the stress test) was an additional within-subjects factor 
next to the three factors mentioned above.  
 
Breath alcohol concentration was expressed as area under the curve (AUC) of all 
measurements. Together with the subjects’ characteristics given in Table 2 it was considered 
one of the secondary variables, which were analyzed for effects of risk group and, where 
applying, administration sequence by univariate ANOVAs for each variable with a continuous 
data structure. Variables with nominal data structure were analyzed by Fisher’s exact tests. 
Subject characteristics that differed significantly between risk groups were corrected for their 
possible confounding influence on the factor effects by including them as a covariate into 
supplementary MANOVAs.  
 
In cases of significant interactions in the MANOVAs, the simple effects were analyzed by 
tests with contrasts to localize exactly the effects of the interacting factors. For all post hoc 
tests the significance level was corrected according to the Bonferroni procedure in order to 
keep the type I error less than or equal to 0.05. Associations between the secretion of AVP, 
ACTH, and cortisol in the various experimental phases were tested by calculating the Pearson 
correlation coefficients. As a nominal level of statistical significance, α=0:05 was accepted.   
 
6. Results  
 
Alcohol administration and the experimental procedures were well tolerated by all subjects. 
None of the participants reported gastrointestinal discomfort.  
 
7. Breath alcohol concentration  
 
BrAC during the time course of the experiments involving alcohol administration is depicted 
in Fig. 1. ANOVA with BrAC AUC as dependent variable did not indicate a significant effect 
of the factors group and administration sequence and no significant factor interaction.  
 
8. Effects on ACTH secretion  
 
Maximum stress-induced ACTH secretion during placebo experiments occurred while the test 
was still ongoing in three subjects (i.e., at 5 or 15 min), immediately after finishing the test (at 
25 min) in 25, and between 35 and 60 min after stress onset in 12 subjects. In experiments 
involving alcohol administration, maximum ACTH secretion during the respective time 
intervals occurred in 9, 24, and 7 subjects.  
 
The MANOVA with baseline ACTH levels revealed no significant influence of risk group, 
treatment, or alcohol administration sequence, and no factor interactions. The repeated-
measures MANOVA with ACTH before the test and maximum stress-induced ACTH levels 
as dependent variables revealed significant effects of stress (Wilks’ multivariate test, F [1, 
36]= 30.5, p < 0.001), of treatment (F [1, 36]=11.7, p=0.002), and of their interaction (F [1, 
36]=9.6, p=0.004). The third-order interaction between stress, treatment, and risk group also 
significantly influenced ACTH (F [1, 36]=6.9, p=0.013). There were no significant main 
effects of group or administration sequence. The source of the third-order interaction was 
further analyzed for simple effects. Tests with contrasts revealed significantly lower peak 
ACTH levels after administration of alcohol compared to placebo in PHA (p < 0.05, see Fig. 
2), but not in FHN subjects. Peak ACTH concentration was marginally higher in PHA than 
FHN subjects during placebo (tests with contrasts, p < 0.09), but not alcohol experiments.  
 
9. Effects on AVP secretion  
 
AVP levels immediately before the stress test were not significantly influenced by risk group, 
treatment, administration sequence, or their interaction (Fig. 2). The repeated-measures 
MANOVA with AVP levels before the stressor and AVP at the time of maximum 
stressinduced ACTH secretion indicated significant effects of stress (Wilks’ multivariate test, 
F [1, 36]=19.4, p < 0.001), and of the interactions between group x treatment (F [1, 36]=4.9, 
p=0.033), and group x treatment x stress (F [1, 36]=5.0, p=0:032). The main effects of group, 
treatment, and administration sequence were not statistically significant. Analysis of the 
simple effects underlying the interaction between group and treatment revealed that AVP 
levels at the time of maximum ACTH secretion were decreased by alcohol administration in 
PHA (p < 0.05, tests with contrasts, Fig. 2), but not FHN subjects, and were significantly 
lower in PHA compared to FHN subjects after alcohol administration (p < 0.05, tests with 
contrasts), but not in placebo experiments.  
 
The repeated-measures MANOVA comparing AVP concentrations before the stressor and at 
75 min revealed no significant effects of stress, group, treatment, or administration sequence, 
and no factor interactions.  
 
 
10. Correlation analysis  
 
Pearson correlation coefficients revealed no significant interrelation between AVP and ACTH 
levels for each of the three time points during either alcohol or placebo experiments.  
 
11. Effects of secondary variables  
 
The subjects’ characteristics considered as secondary variables are given in Table 2. Risk 
group differences were found for sensation seeking scale and urine output during the 
experiment.  
 
When the sensation seeking scale sum score was included as a covariate into the MANOVA 
that analyzed AVP levels before stress and at maximum stress-induced ACTH secretion, a 
significant factor interaction of stress x treatment x sensation seeking was found (F [1, 
35]=5.0, p=0.033). In this analysis, there was only a marginal effect of stress (F [1, 35]=3.8, 
p=0.06), and the main effects of sensation seeking, treatment, risk group, administration 
sequence, and of the factor interactions involving risk group were not statistically significant. 
The sensation seeking scores included as a covariate into the MANOVA analyzing ACTH 
before and after stress did not alter the main effects described above. Plasma osmolality and 
urine volume also did not affect AVP levels when included as a covariate and did not alter the 
influence of the main factors.  
 
12. Discussion  
 
The plasma AVP levels found in this study were within the concentration range usually 
reported in healthy humans (Eisenhofer and Johnson, 1982; Chiodera and Coiro, 1990; Inder 
et al., 1997; Ehrenreich et al., 1997; van Londen et al., 1997; Altemus et al., 2001). The 
psychosocial stress paradigm induced a marked activation of the HPA system, as indicated by 
a significant difference between baseline and peak ACTH levels. This was accompanied by a 
small but significant rise of plasma AVP levels at the time of peak ACTH secretion compared 
to AVP before the stressor. At 50 min after termination of the stress test, AVP concentration 
was back to baseline.  
 
These findings suggest that acute psychosocial stress induces a short-lived stimulation of 
AVP secretion into the systemic circulation. The extent of stress-induced AVP stimulation 
was comparable to that induced by pain (Kendler et al., 1978) or sexual arousal (Murphy et 
al., 1987), but below that induced by surgery (Moran et al., 1964) or exercise stress (Altemus 
et al., 2001). Another study employing a multifaceted psychological stress test found no effect 
on AVP secretion (Ehrenreich et al., 1997). These authors did not measure ACTH or cortisol 
levels, therefore it cannot be excluded that their rather mild stressor was too weak to stimulate 
the HPA system.  
 
Comparison between the risk groups revealed a marginally higher ACTH, but equal AVP 
stress responses in PHA compared to FHN subjects during placebo experiments. In order to 
interpret this variance, the questions of source and functional relevance of peripheral plasma 
AVP levels arise. In various paradigms of psychological stress such as restraint, forced 
swimming, or social defeat, AVP release within the PVN itself was stimulated (Wotjak et al., 
1996), and increased AVP gene transcription was found in both parvocellular (Ma et al., 
1997) and magnocellular neurons of the PVN (Wotjak et al., 2001). Since AVP in the 
systemic circulation is generally assumed to originate from the neurohypophysis and thus 
from magnocellular neurons located in both the hypothalamic PVN and supraoptic nucleus 
(SON), the stimulation of this neuron population upon stressor exposure might underlie the 
increased peripheral AVP levels. In this context it is noteworthy that in animal studies 
involving social defeat or swim stress, stimulation of AVP release within the PVN was not 
associated with increased peripheral AVP levels (Wotjak et al., 1996, 1998). If secreted into 
the portal blood/systemic circulation, AVP can contribute to HPA system stimulation (see 
Romero and Sapolsky, 1996 for review). In humans, this assumption is supported by findings 
of a positive correlation between AVP and ACTH levels in depressive patients (Inder et al., 
1997) and in healthy individuals after i.v. calcium infusion (Chiodera et al., 1997). In the 
stress experiments reported here and during HPA stimulation induced by insulin 
hypoglycemia in obese women (Weaver et al., 1993), such an association could not be 
observed. These findings question a functional role of peripheral AVP regarding stimulation 
of the HPA system in our experimental paradigm. Rather, ACTH and AVP might reflect 
different aspects of the neuroendocrine response to psychosocial stress.  
 
Alcohol administration left baseline ACTH and AVP secretion unaffected and did not alter 
the neuroendocrine stress response in FHN subjects, but attenuated the stress-induced ACTH 
and AVP response in PHA subjects. These results support our main hypothesis, namely that 
alcohol reduces stress-induced HPA activation more effectively in PHA than FHN subjects. 
This is of particular relevance since AVP is secreted directly from the axon terminals of 
hypothalamic neurons and thus reflects central nervous reactivity more closely than does 
anterior pituitary hormone secretion. Together, these findings provide neurobiological 
evidence for a more effective stress response-dampening by alcohol in healthy, nondependent 
subjects with a family genetic risk for alcoholism compared to FHN subjects.  
 
Much of the variance in stress-induced AVP secretion was explained by the subjects’ 
sensation seeking scale scores, which were significantly higher in PHA than FHN subjects. 
This personality dimension is partly determined by genetic factors (Koopmans et al., 1995) 
and largely overlaps with novelty seeking (McCourt et al., 1993). In children, a high score in 
novelty seeking is associated with increased rates of adult alcohol abuse (Cloninger et al., 
1988), and this trait is part of the concept that distinguishes between type I and type II 
alcoholism (Cloninger, 1987). In our sample, the sensation seeking sum score correlated 
negatively with peak AVP levels during alcohol experiments (Pearson correlation coefficient 
r=-0.46, p)=0.003) and positively with their difference between placebo and alcohol condition 
(r=0.47, p=0.002), i.e., higher sensation seeking scores were associated with less AVP 
secretion during alcohol sessions and a stronger stress dampening effect of alcohol across risk 
groups. Therefore, it is possible that the same biological factor underlies both the increased 
sensation seeking and the stronger alcohol effect on stress-induced AVP response in PHA 
subjects.  
 
A confounding effect of age, weight, recent alcohol drinking, cigarette smoking habits, recent 
illegal drug use, individual psychiatric history, or depression on AVP secretion could be 
excluded, since these variables did not differ between risk groups (Table 2). Our data do not 
offer an explanation for the increased urine output in PHA compared to FHN subjects during 
placebo experiments, since baseline plasma osmolality, body weight, and AVP levels did not 
differ between risk groups. Alcohol increased urine output equally between groups in the 
absence of a main effect of alcohol on AVP levels. Therefore, the alcohol-induced diuresis in 
this study was probably not due to impaired AVP secretion.  
 
Interpretation of our results is restricted by several limitations. First, AVP was measured only 
at three time points, which precludes observation of a time course. Therefore it remains to be 
confirmed whether AVP measured at the time of maximum ACTH secretion adequately 
reflects the dynamics of stress-induced changes. Second, blood pressure was taken only 
during the screening visit and not after the stressor, which would have been helpful to 
appraise the functional relevance of AVP response differences between risk groups. Third, 
our efforts to recruit a representative population sample were not completely successful due to 
the high dropout rate before beginning of the experiments. One subject in the PHA group and 
six in the FHN group were acquaintances of the initially recruited probands. However, the 
method of recruitment (representative population sample vs. acquaintances) had no significant 
influence on ACTH or AVP levels before or after stress.  
 
In conclusion, our findings suggest that alcohol dampens the neuroendocrine response after 
exposure to a psychosocial stressor only in sons of alcohol-dependent fathers, but not in 
controls. This is independently indicated by plasma levels of ACTH and AVP. Since stress is 
detrimental to internal homoeostasis and promotes the development of alcohol dependence 
(Koob and Le Moal, 2001), stronger stress response-dampening by alcohol might be 
advantageous to sons of alcoholics in the short term, but also constitute a mechanism by 
which their risk to develop alcohol use disorders is increased.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Acknowledgements  
 
This study was supported by grant LA 1148/1-1 provided by the Deutsche Forschungsgemeinschaft. 
We gratefully acknowledge performance of diagnostic interviews and help with stress tests by Sabine 
Kunz-Ebrecht, Heike Abel and Heidi Westhoven, expert technical support by Marina Zimbelmann and 
Annette Schubert, help with statistical data evaluation by Dr. Alexander Yassouridis and grant 
application by Gabriele Lachner.  
 
References  
 
 Alonso G, Assenmacher I. Radioautographic studies on the neurohypophysial projections of 
the supraoptic and paraventricular nuclei in the rat. Cell Tissue Res 1981;219:525–34. 
 Altemus M, Roca C, Galliven E, Romanos C, Deuster P. Increased vasopressin and 
adrenocorticotropin responses to stress in the midluteal phase of the menstrual cycle. J Clin 
Endocrinol Metab 2001;86:2525–30. 
 Brunner J, Keck ME, Landgraf R, Uhr M, Namendorf C, Bronisch T. Vasopressin in 
depressed suicide attempters: preliminary results. Eur Neuropsychopharmacol 2002;12:489–
94. 
 Chiodera P, Coiro V. Inhibitory effect of ethanol on the arginine vasopressin response to 
insulin-induced hypoglycemia and the role of endogenous opioids. Neuroendocrinology 
1990;51:501–4. 
 Chiodera P, Volpi R, Capretti L, Caffarri G, Pilla S, Coiro V. Stimulation of arginine 
vasopressin secretion by a small increase in blood ionized calcium in normal men. Eur J Clin 
Invest 1997;27:575–8. 
 Cloninger CR. Neurogenetic adaptive mechanisms in alcoholism. Science 1987;236:410–6. 
 Cloninger CR, Sigvardsson S, Bohman M. Childhood personality predicts alcohol abuse in 
young adults. Alcohol Clin Exp Res 1988;12:494–505. 
 Conrod P, Pihl RO, Vassileva J. Differential sensitivity to alcohol reinforcement in groups of 
men at risk for distinct alcoholism subtypes. Alcohol Clin Exp Res 1998;22:585–97. 
 Cotton NS. The familial incidence of alcoholism. A review. J Stud Alcohol 1979;40:89–116. 
 De Vries GJ, van Leeuwen FW, Caffe AR, Swaab DF. The vasopressinergic innervation of the 
brain in normal and castrated rats. J Comp Neurol 1985;233:236–54. 
 de Wied D, Diamant M, Fodor M. Central effects of the neurohypophyseal hormones and 
related peptides. Front Neuroendocrinol 1993;14:251–302. 
 Dugue B, Leppanen EA, Teppo AM, Fyhrquist F, Grasbeck R. Effects of psychological stress 
on plasma interleukins-1. Scand J Clin Lab Invest 1993;53:555–61. 
 Ehrenreich H, tom Dieck K, Gefeller O, Kaw S, Schilling L, Poser W, Rüther E. Sustained 
elevation of vasopressin plasma levels in healthy young men, but not in abstinent alcoholics, 
upon expectation of novelty. Psychoneuroendocrinology 1997;22:13–24. 
 Eisenhofer G, Johnson RH. Effect of ethanol ingestion on plasma vasopressin and water 
balance in humans. Am J Physiol 1982;242:R522–7. 
 Engelmann M, Wotjak CT, Neumann I, Ludwig M, Landgraf R. Behavioral consequences of 
intracerebral vasopressin and oxytocin: focus on learning and memory. Neurosci Biobehav 
Rev 1996;20:341–58. 
 Finn PR, Zeitouni NC, Pihl RO. Effects of alcohol on psychophysiological hyperreactivity to 
nonaversive and aversive stimuli in men at high risk for alcoholism. J Abnorm Psychol 
1990;99:79–85. 
 Gianoulakis C, Guillaume P, Thavundayil J, Gutkowska J. Increased plasma atrial natriuretic 
peptide after ingestion of low doses of ethanol in humans. Alcohol Clin Exp Res Clin Exp Res 
1997;21:162–70. 
 Hatton GI. Emerging concepts of structure–function dynamics in adult brain: the 
hypothalamo-neurohypophysial system. Prog Neurobiol 1990;34:437–504. 
 Herman JP. In situ hybridization analysis of vasopressin gene transcription in the 
paraventricular and supraoptic nuclei of the rat: regulation by stress and glucocorticoids. J 
Comp Neurol 1995;363:15–27. 
 Heuser I, Bissette G, Dettling M, Schweiger U, Gotthard U, Schmider J, Lammers C-H, 
Nemeroff CB, Holsboer F. Cerebrospinal fluid concentrations of corticotropin-releasing 
hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response 
to amitriptyline treatment. Depress Anxiety 1998;8:71–9. 
 Holsboer F, Barden N. Antidepressants and hypothalamic–pituitary–adrenocortical regulation. 
Endocr Rev 1996;17:187–205. 
 Hussy N, Deleuze C, Desarmenien MG,Moos FC. Osmotic regulation of neuronal activity: a 
new role for taurine and glial cells in a hypothalamic neuroendocrine structure. Prog 
Neurobiol 2000;62:113–34. 
 Inder WJ, Donald RA, Prickett TCR, Frampton CM, Sullivan PF, Mulder RT, Joyce PR. 
Arginine vasopressin is associated with hypercortisolemia and suicide attempts in depression. 
Biol Psychiatry 1997;42:744–7. 
 Inder WJ, Joyce PR, Wells JE, Evans MJ, Ellis MJ, Mattioli L, Donald RA. The acute effects 
of oral ethanol on the hypothalamic–pituitary–adrenal axis in normal human subjects. Clin 
Endocrinol (Oxf) 1995;42:65–71. 
 Kendler KS, Weitzman RE, Fisher DA. The effect of pain on plasma arginine vasopressin 
concentrations in man. Clin Endocrinol (Oxf) 1978;8:89–94. 
 Kirschbaum C, Pirke KM, Hellhammer DH. The ‘Trier social stress test’ – a tool for 
investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 
1993;28:76–81. 
 Koob GF, Le Moal M. Drug addiction, dysregulation of reward, and allostasis. 
Neuropsychopharmacology 2001;24:97–129.  
 Koopmans JR, Boomsma DI, Heath AC, Doornen LJP. A multivariate genetic analysis of 
sensation seeking. Behav Genet 1995;25:349–56. 
 Landgraf R. Intracerebrally released vasopressin and oxytocin: measurement, mechanisms and 
behavioral consequences. J Neuroendocrinol 1995;7:243–53. 
 Landgraf R. Neuropeptides and anxiety-related behavior. Endocr J 2001;48:517–33. 
 Laux L, Glanzmann P, Schaffner P, Spielberger CD. Das State-Trait-Angstinventar. 
Theoretische Grundlagen und Handanweisung, Weinheim, Beltz, 1981. 
 Leppaluoto J, Vuolteenaho O, Arjamaa O, Ruskoaho H. Plasma immunoreactive atrial 
natriuretic peptide and vasopressin after ethanol intake in man. Acta Physiol Scand 
1992;144:121–7. 
 Levenson RW, Oyama ON, Meek PS. Greater reinforcement from alcohol for those at risk: 
parental risk, personality risk, and sex. J Abnorm Psychol 1987;96:242–53. 
 Lieb R, Isensee B, von Sydow K, Wittchen HU. The early developmental stages of 
psychopathology study (EDSP): a methodological update. Eur Addict Res 2000;6:170–82. 
 Lightman S. Central nervous system control of fluid balance: physiology and pathology. Acta 
Neurochir Suppl 1990;47:90–4. 
 Ma XM, Levy A, Lightman SL. Rapid changes in heteronuclear RNA for corticotrophin-
releasing hormone and arginine vasopressin in response to acute stress. J Endocrinol 
1997;152:81–9. 
 Madrid GA, MacMurray J, Lee JW, Anderson BA, Comings DE. Stress as a mediating factor 
in the association between the DRD2 TaqI polymorphism and alcoholism. Alcohol 
2001;23:117–22. 
 McCourt WF, Gurrera RJ, Cutter HS. Sensation seeking and novelty seeking. are they the 
same. J Nerv Mental Dis 1993;181: 309–12. 
 Moran WH, Miltenberger FW, Shuayb WA, Zimmermann B. The relationship of antidiuretic 
hormone secretion to surgical stress. Surgery 1964;56:99–108. 
 Murphy MR, Seckl JR, Burton S, Checkley SA, Lightman SL. Changes in oxytocin and 
vasopressin secretion during sexual activity in men. J Clin Endocrinol Metab 1987;65:738–41. 
 Newlin DB, Thomson JB. Alcohol challenge with sons of alcoholics: a critical review and 
analysis. Psychol Bull 1990;180:383–402. 
 Plotsky PM. Pathways to the secretion of adrenocorticotropin: a view from the portal. J 
Neuroendocrinol 1991;3:1–9. 
 Prescott CA, Kendler KS. Genetic and environmental contributions to alcohol abuse and 
dependence in a population-based sample of male twins. Am J Psychiatry 1999;156:34–40. 
 Romero LM, Sapolsky RM. Patterns of ACTH secretagog secretion in response to 
psychological stimuli. J Neuroendocrinol 1996;8:243–58. 
 Sinha R, Robinson J, O’Malley S. Stress response dampening: effects of gender and family 
history of alcoholism and anxiety disorders. Psychopharmacology 1998;137:311–20. 
 Sinha R. How does stress increase risk of drug abuse and relapse. Psychopharmacology 
2001;158:343–59. 
 van Londen L, Goekoop GJ, Van Kempen GM, Frankhuijzen-Sierevogel AC, Wiegant VM, 
de Wied D. Plasma levels of arginine vasopressin elevated in patients with major depression. 
Neuropsychopharmacology 1997;17:284–92. 
 Weaver JU, Kopelman PG, McLoughlin L, Forsling ML, Grossman Hyperactivity of the 
hypothalamo–pituitary–adrenal axis in obesity: a study of ACTH, AVP, beta-lipotrophin and 
cortisol responses to insulin-induced hypoglycaemia. Clin Endocrinol 1993;39:345–50. 
 Wigger A, Sánchez MM, Mathys KC, Ebner K, Frank E, Liu D, Kresse A, Neumann ID, 
Holsboer F, Plotsky PM, Landgraf R. Alterations in central neuropeptide expression, release, 
and receptor binding in rats bred for high anxiety: critical role of vasopressin. 
Neuropsychopharmacology 2004;29:1–14. 
 Wotjak CT, Kubota M, Liebsch G, Montkowski A, Holsboer F, Neumann I, Landgraf R. 
Release of vasopressin within the rat paraventricular nucleus in response to emotional stress: a 
novel mechanism of regulating adrenocorticotropic hormone secretion. J Neurosci 
1996;16:7725–32. 
 Wotjak CT, Ganster J, Kohl G, Holsboer F, Landgraf R, Engelmann M. Dissociated central 
and peripheral release of vasopressin, but not oxytocin, in response to repeated swim stress: 
new insights into the secretory capacities of peptidergic neurons. Neuroscience 1998;85:1209–
22. 
 Wotjak CT, Naruo T, Muraoka S, Simchen R, Landgraf R, Engelmann M. Forced swimming 
stimulates the expression of vasopressin and oxytocin in magnocellular neurons of the rat 
hypothalamic paraventricular nucleus. European J Neurosci 2001;13:2273–81. 
 Zimmermann U, Spring K, Kunz S, Lachner G, Uhr M, Wittchen HU, Holsboer F. Effect of 
ethanol on hypothalamic–pituitary–adrenal system response to psychosocial stress in sons of 
alcohol-dependent fathers, Neuropsychopharmacology, in press. Published online at 1/2/04: 
http://www.acnp.org/citations/NPP01020403330/default.pdf. 
 Zuckerman M, Buchsbaum MS, Murphy DL. Sensation seeking and its biological correlates. 
Psychol Bull 1980;88:187–214. 
